LeMaitre Vascular completes $172.5 million convertible senior notes offering due 2030
LeMaitre Vascular issued $172.5 million of 2.50% convertible senior notes due 2030 on December 19, 2024, including the full $22.5 million option exercised by the initial purchasers. The company says it will use the net proceeds for working capital and general purposes, which may include acquisitions or investments, and the notes add debt that can convert into common stock at about $119.73 per share.
Key points
- Notes: $172.5 million principal, 2.50% annual interest, maturing February 1, 2030
- Initial conversion price of approximately $119.73 per share (8.3521 shares per $1,000 principal)
- Company may settle conversions in cash, shares, or a combination; notes redeemable on or after February 5, 2028 under stated conditions
- Notes are unsecured senior obligations under an indenture with U.S. Bank Trust Company, National Association, as trustee
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:54 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 19, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.